Title: – Relationship of Alpha Drugs with Nifty 50
Author: – Anas Khan (MMS First Year Batch B, Roll no. 0222089) Kohinoor Business School, Kurla.
Introduction:
Alpha Drugs, was established in the year 2003 since then have been engaged in Manufacturing, Exporting and Suppliing Pharmaceutical Products like Syrups, Medicines, Injections Etc.
With a worthy experience, provide a wide range of Pharmaceutical Bulk Drugs. Manufacture, export and supply a diverse and qualitative range of Allopathic Medicines, Moreover range comprises Tablet, Ace-SP, Advance-625, Ethixim-O, Othoflam Capsule, Anti-OD, Emlox-DC, Meco Power Plus, Ethisule, Injection, Emiaktion-500, E Panta, Ethitram, Syrup, RB Plus, Ezeekuf, Vitbitone and many others. These are formulated using superior quality of ingredients at the manufacturers end. An expert team of quality controllers, which is responsible to stringently monitor complete ongoing business at each and every stage right from the sourcing of products till the final dispatch at the clients end. Apart from this, Also offer quality packaging of our products in laminated and waterproof sealed packets to ensure safe and flawless delivery of products. Follow ethical business policies that assure us to prompt & timely deliver, products at market leading prices which lead top pharma company in India. Due to this, able to cater huge client base across the globe.
Objective: To Calculate the Beta of Alpha Drugs and find out its significance.
Views and Reviews
Mr. Tripinder Sahi, Owner of Alpha Drugs
“Alpha Drugs is expanding its PCD Pharma Franchise opportunity mainly to promote and develop healthcare in every nook of the nation. Our organization is completely quality driven and committed towards providing reliable, safe and high quality medications. The company is linking with the distributors across Pan India and supporting them through good quality products, with timely deliveries. Customer satisfaction is our main focus. We are committed towards the product demand of our clients and are adequately geared up to add more products based on the on-going market demand.”
Data Collections:
Data is taken from 01-06-2022 to 31-07-2023. It has been downloaded from the NSE site, then Friday’s closing price was sorted and weekly returns of Nifty (i.e. X) and Alpha Drugs (i.e. Y) were calculated.
Data Analysis: – Y^ = -0.5842+1.4195X
(3.7792)
N = 45, R square = 0.2493, F = 14.2825
The above equation shows the relationship between Nifty 50 (X) and Alpha Drugs (Y). The negative sign means negative relationship meaning if X rises Y falls and vice versa. If Nifty 50 (X) rises by 1 unit Alpha Drugs (Y) falls by 1.4195 unit. N means there are 45 observations. T stat for b is 3.7792, is more than tabulated t (t.05,48df = 2.01) therefor t stat for b is statistically significant @5% level. R square is 0.2493 which means 24.9% of Y is explained by X balance 75.1% is error due to variables which are not in model. F is 14.2825 which is less than table value (F.05,1df,48df = 4.1173) so overall the model is statistically not significant at 5% level.
Conclusion:
As, Beta (b) is more than 1, which implies Alpha Drugs good for short term investment.